Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy.
Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women.
Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M, Li Y, Li S, Lv J.
Front Endocrinol (Lausanne). 2022 Apr 7;13:851941. doi: 10.3389/fendo.2022.851941. eCollection 2022.
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes.
Park JJ.
Diabetes Metab J. 2021 Mar;45(2):146-157. doi: 10.4093/dmj.2020.0282. Epub 2021 Mar 25.
Molecular mechanisms of diabetic cardiomyopathy.
Bugger H, Abel ED.
Diabetologia. 2014 Apr;57(4):660-71. doi: 10.1007/s00125-014-3171-6. Epub 2014 Jan 30.
Oxidative stress and diabetic complications.
Giacco F, Brownlee M.
Circ Res. 2010 Oct 29;107(9):1058-70. doi: 10.1161/CIRCRESAHA.110.223545.
Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus.
Huang Q, Tian L, Zhang Y, Qiu Z, Lei S, Xia ZY.
Biomed Pharmacother. 2023 Jul;163:114795. doi: 10.1016/j.biopha.2023.114795. Epub 2023 May 3.
Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus.
Sha W, Hu F, Xi Y, Chu Y, Bu S.
J Diabetes Res. 2021 Jun 28;2021:9999612. doi: 10.1155/2021/9999612. eCollection 2021.
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Hölscher ME, Bode C, Bugger H.
Int J Mol Sci. 2016 Dec 18;17(12):2136. doi: 10.3390/ijms17122136.
Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.
Ng ACT, Delgado V, Borlaug BA, Bax JJ.
Nat Rev Cardiol. 2021 Apr;18(4):291-304. doi: 10.1038/s41569-020-00465-5. Epub 2020 Nov 13.
Association of type 2 diabetes mellitus with the development of new-onset atrial fibrillation in patients with non-ischemic dilated cardiomyopathy: impact of SGLT2 inhibitors.
Tanaka H, Tatsumi K, Matsuzoe H, Soga F, Matsumoto K, Hirata KI.
Int J Cardiovasc Imaging. 2021 Apr;37(4):1333-1341. doi: 10.1007/s10554-020-02122-x. Epub 2021 Jan 4.
Magnetic resonance imaging of diabetic cardiomyopathy.
Madsen PL, Bojer AS, Sørensen M, Gæde P.
Ugeskr Laeger. 2022 Oct 17;184(42):V04220237.
